17,520 resources
By Version
By Realm
Start Prev Rows 12000 - 12200 Next
Package | Version | Identity | Name/Title | Status | FMM | WG | Date | Realm | Source(s) |
---|---|---|---|---|---|---|---|---|---|
hl7.eu.fhir.pcsp | R4 | vs-sct-sourceType-eu-pcsp | Stem Cell Source type | draft | 2025-07 | eu | internal | ||
hl7.eu.fhir.pcsp | R4 | vs-sct-type-eu-pcsp | Stem Cell Transplantation type | draft | 2025-07 | eu | sct | ||
nictiz.fhir.nl.stu3.zib2017 | R3 | 2.16.840.1.113883.2.4.3.11.60.40.2.5.2.3--20171231000000 | StomaLateraliteitCodelijst | active | nl | sct | |||
nictiz.fhir.nl.r4.zib2020 | R4 | 2.16.840.1.113883.2.4.3.11.60.40.2.5.2.1--20200901000000 | StomaTypeCodelijst | active | nl | sct tho | |||
nictiz.fhir.nl.stu3.zib2017 | R3 | 2.16.840.1.113883.2.4.3.11.60.40.2.5.2.1--20171231000000 | StomaTypeCodelijst | active | nl | fhir sct | |||
de.netzwerk-universitaetsmedizin.ebm-cpg | R5 | ceosys-vs-recommendation-strength | Recommendation Strength | draft | 2022-09 | uv | internal | ||
hl7.fhir.us.registry-protocols | R4 | StressTestResults | Stress Test Results | active | cic | 2023-11 | us | fhir | |
hl7.fhir.us.registry-protocols | R4 | StressTestRiskExtentofIschemia | Stress Test Risk/Extent of Ischemia | active | cic | 2023-11 | us | fhir | |
hl7.terminology | R5 | definition-use | Structure Definition Use Codes / Keywords | active | 2020-02 | uv | tho | ||
hl7.terminology | R5 | v3-SubarachnoidRoute | SubarachnoidRoute | active | 2014-03 | uv | tho | ||
hl7.terminology | R5 | v3-SubconjunctivalRoute | SubconjunctivalRoute | active | 2014-03 | uv | tho | ||
hl7.terminology | R5 | v3-SubcutaneousRoute | SubcutaneousRoute | active | 2014-03 | uv | tho | ||
hl7.fhir.dk.core | R4 | dk-core-RegionalSubDivisionCodes | DK Regional Subdivision Codes | active | 2025-02 | dk | internal | ||
openehr.base | R5 | subject-relationship | Subject Relationship | informative | 3 | fhir | 2024-08 | uv | |
hl7.fhir.nl.zorgviewer | R3 | SubjectRoleCodelist | Subject rol (beroepen) waardelijst | active | 2025-07 | nl | sct | ||
hl7.terminology | R5 | v3-SublesionalRoute | SublesionalRoute | active | 2014-03 | uv | tho | ||
hl7.terminology | R5 | v3-SublingualRoute | SublingualRoute | active | 2014-03 | uv | tho | ||
hl7.fhir.us.registry-protocols | R4 | SubmissionType | Submission Type | active | cic | 2023-11 | us | fhir | |
ca.ab.fhir.psab | R4 | submission-metadata | SubmissionMetadata | draft | 2024-06 | ca | |||
ch.fhir.ig.ch-term | R4 | SubmissionSet.Author.AuthorRole | SubmissionSet.Author.AuthorRole | active | 2025-05 | ch | oid | ||
ch.fhir.ig.ch-epr-term | R4 | SubmissionSet.Author.AuthorRole | SubmissionSet.Author.AuthorRole | active | 2023-12 | ch | oid | ||
ch.fhir.ig.ch-term | R4 | SubmissionSet.contentTypeCode | SubmissionSet.contentTypeCode | active | 2025-05 | ch | sct | ||
ch.fhir.ig.ch-epr-term | R4 | SubmissionSet.contentTypeCode | SubmissionSet.contentTypeCode | active | 2023-12 | ch | sct | ||
hl7.terminology | R5 | v3-SubmucosalRoute | SubmucosalRoute | active | 2014-03 | uv | tho | ||
hl7.fhir.uv.aitransparency | R4 | ProvenanceVS | Recommended provenance codes | draft | 0 | ehr | 2025-06 | uv | fhir tho |
hl7.terminology | R5 | fhir-clinical-doc-information-recipient | FHIR Clinical Document Information Recipients Participant Types | active | sd | 2025-04 | uv | tho | |
hl7.fhir.us.pacio-pfe | R4 | pfe-us-core-category-vs | Personal Functioning and Engagement US Core Value Set | trial-use | 3 | pc | 2025-07 | us | fhir |
uk.nhsdigital.r4.test | R4 | UKCore-England-organisation-type | NHSMIMOrganisationType | draft | |||||
hl7.terminology | R5 | substance-category | Substance Category Codes | active | 2 | oo | 2024-04 | uv | tho |
hl7.fhir.us.pq-cmc-fda | R5 | substance-classification | Substance Classification | trial-use | 2 | brr | 2025-07 | us | ncit |
hl7.fhir.uv.emedicinal-product-info | R5 | substance | Substances | active | 2025-07 | uv | |||
hl7.terminology | R5 | v3-SubstanceAdminGenericSubstitution | SubstanceAdminGenericSubstitution | active | 2014-03 | uv | tho | ||
hl7.fhir.ee.mpi | R5 | person-relationship | Person Relationship | draft | 2023-12 | ee | sct | ||
de.netzwerk-universitaetsmedizin.ebm-cpg | R5 | vs-rating-benefit-and-harms | Rating Benefit And Harms | draft | 2022-09 | uv | internal | ||
hl7.terminology | R5 | v3-SupernumeraryTooth | SupernumeraryTooth | active | 2014-03 | uv | tho | ||
hl7.terminology | R5 | measure-supplemental-data | Measure Supplemental Data | active | cqi | 2023-02 | uv | tho | |
hl7.terminology | R5 | v3-ActClassSupply | ActClassSupply | active | 2014-03 | uv | tho | ||
hl7.terminology | R5 | v3-SupplyDetectedIssueCode | SupplyDetectedIssueCode | active | 2014-03 | uv | tho | ||
hl7.terminology | R5 | v3-GeneralPurposeOfUse | GeneralPurposeOfUse | active | 2014-03 | uv | tho | ||
hl7.terminology | R5 | v3-PurposeOfUse | PurposeOfUse | active | 2024-02 | uv | tho | ||
hl7.terminology | R5 | v3-SuppositoryRoute | SuppositoryRoute | active | 2014-03 | uv | tho | ||
hl7.fhir.us.registry-protocols | R4 | SurgicalRisk | SurgicalRisk | active | cic | 2023-11 | us | fhir | |
hl7.eu.fhir.idea4rc | R4 | surgery-complication-eu-i4rc | Surgery Complication | active | 2025-07 | eu | |||
hl7.eu.fhir.idea4rc | R4 | surgery-intention-eu-i4rc | Surgery Intention | active | 2025-07 | eu | |||
hl7.eu.fhir.idea4rc | R4 | surgery-outcome-eu-i4rc | Surgery Outcome | active | 2025-07 | eu | |||
hl7.eu.fhir.pcsp | R4 | vs-action-eu-pcsp | Surgical Actions | draft | 2025-07 | eu | internal sct | ||
hl7.fhir.us.ccda | R4 | 2.16.840.1.113883.11.20.1.1 | SurgicalOperationNoteDocumentTypeCode | trial-use | cgp | 2018-05 | us | loinc | |
hl7.terminology | R5 | v3-Swish | Swish | active | 2014-03 | uv | tho | ||
nictiz.fhir.nl.r4.zib2020 | R4 | 2.16.840.1.113883.2.4.3.11.60.40.2.8.2.5--20200901000000 | SymptoomCodelijst | active | nl | sct tho | |||
nictiz.fhir.nl.stu3.zib2017 | R3 | 2.16.840.1.113883.2.4.3.11.60.40.2.8.2.5--20171231000000 | SymptoomCodelijst | active | nl | fhir sct | |||
hl7.fhir.us.registry-protocols | R4 | SyntaxScore | Syntax Score for the PCI procedure | active | cic | 2023-11 | us | fhir | |
hl7.fhir.us.vrdr | R4 | vrdr-system-reject-vs | System Reject ValueSet | active | pher | 2024-10 | us | fhir | |
hl7.fhir.eu.base-r5 | R5 | oid-ehicPersonalId | EHIC Personal ID (system IDs - oid) | draft | 2025-05 | eu | ietf | ||
hl7.fhir.eu.base | R4 | oid-ehicPersonalId | EHIC Personal ID (system IDs - oid) | draft | 2025-05 | eu | ietf | ||
hl7.fhir.eu.base-r5 | R5 | uri-ehicPersonalId | EHIC Personal ID (system IDs - uri) | draft | 2025-05 | eu | ietf | ||
hl7.fhir.eu.base | R4 | uri-ehicPersonalId | EHIC Personal ID (system IDs - uri) | draft | 2025-05 | eu | ietf | ||
us.nlm.vsac | R4 | 1.3.6.1.4.1.6997.4.1.2.265.15.31305.1.11.2.999.193 | Conditions Associated with Head and Neck Radiotherapy | active | 2017-03 | us | icd | ||
hl7.eu.fhir.pcsp | R4 | mcode-cancer-staging-system-vs | Cancer Staging System Value Set | draft | 2025-07 | eu | sct | ||
hl7.fhir.us.registry-protocols | R4 | TIMIFlow | TIMI Flow | active | cic | 2023-11 | us | sct | |
hl7.terminology | R5 | adverse-event-causality-method | AdverseEventCausalityMethod | active | 1 | pc | 2024-04 | uv | tho |
nictiz.fhir.nl.r4.zib2020 | R4 | 2.16.840.1.113883.2.4.3.11.60.40.2.7.2.2--20200901000000 | TabakGebruikStatusCodelijst | active | nl | sct tho | |||
de.fhir.medication | R4 | TimingWhenDgMP | Timing When dgMP | draft | 2025-07 | fhir | |||
hl7.terminology | R5 | subscription-tag | SubscriptionTag | draft | fhir | 2020-02 | uv | tho | |
hl7.fhir.us.pco | R4 | prom-target-measures | PROM Target Measure Scores | draft | 2 | pc | 2025-03 | us | loinc |
hl7.terminology | R5 | v3-ParticipationBeneficiary | ParticipationBeneficiary | active | 2014-03 | uv | tho | ||
ca.on.oh-olis | R4 | olis-NatureOfAbnormalTest | NatureOfAbnormalTest | active | tho | ||||
hl7.terminology | R5 | v3-ParticipationIndirectTarget | ParticipationIndirectTarget | active | 2014-03 | uv | tho | ||
hl7.terminology | R5 | v3-ParticipationTargetDirect | ParticipationTargetDirect | active | 2014-03 | uv | tho | ||
hl7.terminology | R5 | v3-ParticipationConsumable | ParticipationConsumable | active | 2014-03 | uv | tho | ||
hl7.fhir.au.ereq | R4 | au-erequesting-task-businessstatus | AU eRequesting Task Business Status | draft | 0 | 2025-05 | au | tho | |
hl7.fhir.au.ereq | R4 | au-erequesting-task-status | AU eRequesting Task Status | draft | 0 | 2024-09 | au | fhir | |
hl7.fhir.au.ereq | R4 | au-erequesting-fulfilment-task-tags | AU eRequesting Fulfilment Task Tags | draft | 0 | 2025-01 | au | tho | |
hl7.fhir.uv.phenomics-exchange | R4 | Taxonomy | Taxonomy | draft | cic | 2020-02 | uv | ||
nictiz.fhir.nl.r4.zib2020 | R4 | 2.16.840.1.113883.2.4.3.11.60.40.2.4.11.2--20200901000000 | TeKledenLichaamsdeelCodelijst | active | nl | sct | |||
nictiz.fhir.nl.stu3.zib2017 | R3 | 2.16.840.1.113883.2.4.3.11.60.40.2.4.11.2--20171231000000 | TeKledenLichaamsdeelCodelijst | active | nl | sct | |||
nictiz.fhir.nl.r4.zib2020 | R4 | 2.16.840.1.113883.2.4.3.11.60.40.2.4.10.2--20200901000000 | TeWassenLichaamsdeelCodelijst | active | nl | sct | |||
nictiz.fhir.nl.stu3.zib2017 | R3 | 2.16.840.1.113883.2.4.3.11.60.40.2.4.10.2--20171231000000 | TeWassenLichaamsdeelCodelijst | active | nl | sct | |||
hl7.terminology | R5 | v3-ObservationInterpretationExceptions | ObservationInterpretationExceptions | active | 2014-03 | uv | tho | ||
hl7.fhir.us.codex-radiation-therapy | R4 | codexrt-radiotherapy-free-breathing-motion-mgmt-technique-vs | Radiotherapy Free-Breathing Motion Management Technique Value Set | active | cgp | 2025-02 | us | sct | |
nictiz.fhir.nl.r4.zib2020 | R4 | 2.16.840.1.113883.2.4.3.11.60.40.2.13.2.2--20200901000000 | TekstStatusCodelijst | active | nl | oid | |||
nictiz.fhir.nl.stu3.zib2017 | R3 | 2.16.840.1.113883.2.4.3.11.60.40.2.13.2.2--20171231000000 | TekstStatusCodelijst | active | nl | oid | |||
nictiz.fhir.nl.r4.zib2020 | R4 | 2.16.840.1.113883.2.4.3.11.60.40.2.13.2.1--20200901000000 | TekstUitslagTypeCodelijst | active | nl | sct | |||
nictiz.fhir.nl.stu3.zib2017 | R3 | 2.16.840.1.113883.2.4.3.11.60.40.2.13.2.1--20171231000000 | TekstUitslagTypeCodelijst | active | nl | sct | |||
nictiz.fhir.nl.r4.zib2020 | R4 | 2.16.840.1.113883.2.4.3.11.60.40.2.20.6.1--20200901000000 | TelecomTypeCodelijst | active | nl | tho oid | |||
nictiz.fhir.nl.stu3.zib2017 | R3 | 2.16.840.1.113883.2.4.3.11.60.40.2.20.6.1--20171231000000 | TelecomTypeCodelijst | active | nl | fhir oid | |||
signal.core.r4 | R4 | contact-point-system | ContactPointSystem | draft | 0 | fhir | 2019-10 | us | fhir |
nictiz.fhir.nl.r4.zib2020 | R4 | ContactInformation-TelephoneNumbersSystem | ContactPointSystem ValueSet for zib ContactInformation TelephoneNumbers | active | nl | fhir | |||
nhsd.assets.stu3 | R3 | EMS-ContactPointSystem-1 | ContactPointSystem | draft | 0 | fhir | 2017-04 | fhir | |
hl7.terminology | R5 | v3-LocalMarkupIgnore | LocalMarkupIgnore | active | 2014-03 | uv | tho | ||
nictiz.fhir.nl.r4.zib2020 | R4 | 2.16.840.1.113883.2.4.3.11.60.40.2.12.6.1--20200901000000 | TemperatuurTypeCodelijst | active | nl | sct | |||
nictiz.fhir.nl.stu3.zib2017 | R3 | 2.16.840.1.113883.2.4.3.11.60.40.2.12.6.1--20171231000000 | TemperatuurTypeCodelijst | active | nl | sct | |||
hl7.fhir.us.vitals | R4 | MeasurementProtocolVS | Measurement Protocol value set | draft | 2024-10 | us | fhir | ||
hl7.fhir.us.cardx-htn | R4 | MeasurementProtocolVS | Measurement Protocol value set | draft | 2023-08 | us | fhir | ||
hl7.terminology | R5 | v3-Loan | Loan | active | 2014-03 | uv | tho | ||
ee.fhir.terminology | R5 | teovoime-staatus | Teovõime staatus | active | 2025-06 | ee | internal | ||
openehr.base | R5 | term-binding-type | Term Binding Type ValueSet | informative | 3 | fhir | 2024-08 | uv | |
openehr.base | R5 | term-mapping-purpose | Term Mapping Purpose | informative | 3 | fhir | 2024-08 | uv | |
hl7.fhir.us.pco | R4 | goal-barrier-codes | Goal Barrier Assessment Codes | draft | 2 | pc | 2025-03 | us | sct |
hl7.fhir.us.pco | R4 | readiness-assessment-codes | Readiness Assessment Codes | draft | 2 | pc | 2025-03 | us | fhir |
hl7.fhir.us.pq-cmc-fda | R5 | spl-pharmaceutical-dosage-form-terminology | Pharmaceutical Dosage Form Terminology | trial-use | 2 | brr | 2025-07 | us | ncit |
hl7.fhir.us.pq-cmc-fda | R5 | spl-drug-route-of-administration-terminology | Drug Route Of Administration Terminology | trial-use | 2 | brr | 2025-07 | us | ncit |
hl7.fhir.us.pq-cmc-fda | R5 | pqcmc-name-part-terminology | PQCMC Name Part Terminology | trial-use | 2 | brr | 2025-07 | us | tho |
hl7.fhir.us.pq-cmc-fda | R5 | pqcmc-batch-utilization-terminology | Batch utilization Terminology | trial-use | 2 | brr | 2025-07 | us | ncit |
hl7.fhir.us.pq-cmc-fda | R5 | pqcmc-chemical-structure-datafile-type-terminology | Chemical Structure Data File Type Terminology | trial-use | 2 | brr | 2025-07 | us | ncit |
hl7.fhir.us.pq-cmc-fda | R5 | pqcmc-closure-type-terminology | Closure Type Terminology | trial-use | 2 | brr | 2025-07 | us | ncit |
hl7.fhir.us.pq-cmc-fda | R5 | pqcmc-container-type-terminology | Container Type Terminology | trial-use | 2 | brr | 2025-07 | us | ncit |
hl7.fhir.us.pq-cmc-fda | R5 | pqcmc-drug-product-component-function-category-terminology | Drug Product Component Function Category Terminology | trial-use | 2 | brr | 2025-07 | us | ncit |
hl7.fhir.us.pq-cmc-fda | R5 | pqcmc-excipient-function-terminology | Excipient Function Terminology | trial-use | 2 | brr | 2025-07 | us | ncit |
hl7.fhir.us.pq-cmc-fda | R5 | pqcmc-impurity-classification-terminology | Impurity Classification Terminology | trial-use | 2 | brr | 2025-07 | us | ncit |
hl7.fhir.us.pq-cmc-fda | R5 | pqcmc-quality-benchmark-terminology | Quality Benchmark Terminology | trial-use | 2 | brr | 2025-07 | us | ncit |
hl7.fhir.us.pq-cmc-fda | R5 | pqcmc-source-type-terminology | Source Type Terminology | trial-use | 2 | brr | 2025-07 | us | ncit |
hl7.fhir.us.pq-cmc-fda | R5 | pqcmc-specification-status-terminology | Specification Status Terminology | trial-use | 2 | brr | 2025-07 | us | ncit |
hl7.fhir.us.pq-cmc-fda | R5 | pqcmc-specification-type-terminology | Specification Type Terminology | trial-use | 2 | brr | 2025-07 | us | ncit |
hl7.fhir.us.pq-cmc-fda | R5 | pqcmc-strength-type-terminology | Strength Type Terminology | trial-use | 2 | brr | 2025-07 | us | ncit |
hl7.fhir.us.pq-cmc-fda | R5 | pqcmc-test-category-terminology | Test Category Terminology | trial-use | 2 | brr | 2025-07 | us | ncit |
hl7.fhir.us.pq-cmc-fda | R5 | pqcmc-test-method-origin-terminology | Test Method Origin Terminology | trial-use | 2 | brr | 2025-07 | us | ncit |
hl7.fhir.us.pq-cmc-fda | R5 | pqcmc-test-usage-terminology | Test Usage Terminology | trial-use | 2 | brr | 2025-07 | us | ncit |
hl7.fhir.us.pq-cmc-fda | R5 | pqcmc-manufactured-dose-form-terminology | Manufactured Dose Form Terminology | trial-use | 2 | brr | 2025-07 | us | ncit |
hl7.fhir.us.pq-cmc-fda | R5 | pqcmc-units-of-measure | Units Of Measure | trial-use | 2 | brr | 2025-07 | us | ucum |
openehr.base | R5 | territories | Territories | informative | 3 | fhir | 2024-08 | uv | iso |
hl7.terminology | R5 | v3-tst0280 | _0280 | active | 2014-03 | uv | tho | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1032.319 | Steward Transfer Test | active | 2024-07 | us | rx | ||
ca.on.oh-olis | R4 | olis-TestRequestCodes | TestRequestCodes | active | |||||
hl7.eu.fhir.idea4rc | R4 | simpleResult-eu-i4rc | Simple measures | active | 2025-07 | eu | |||
nictiz.fhir.nl.r4.zib2020 | R4 | 2.16.840.1.113883.2.4.3.11.60.40.2.13.1.15--20200901000000 | TestUitslagStatusCodelijst | active | nl | oid | |||
hl7.terminology | R5 | v3-tst0272 | _0272 | active | 2014-03 | uv | tho | ||
nictiz.fhir.nl.r4.zib2020 | R4 | 2.16.840.1.113883.2.4.3.11.60.40.2.13.1.4--20200901000000 | TestmethodeCodelijst | active | nl | sct | |||
hl7.fhir.be.nihdi-terminology | R4 | be-vs-speech-therapy-pathology-situation-code | Speech Therapy Pathology Situation Code | trial-use | 1 | fhir | 2025-02 | be | internal |
ch.fhir.ig.ch-elm | R4 | ch-elm-results-bot-org | CH ELM Results Bot Org | active | 2025-06 | ch | |||
ch.fhir.ig.ch-elm | R4 | ch-elm-results-bot-spec | CH ELM Results Bot Spec | active | 2025-06 | ch | |||
ch.fhir.ig.ch-elm | R4 | ch-elm-results-bru-org | CH ELM Results Bru Org | active | 2025-06 | ch | sct | ||
ch.fhir.ig.ch-elm | R4 | ch-elm-results-camp-diar-org | CH ELM Results Camp Diar Org | active | 2025-06 | ch | sct | ||
ch.fhir.ig.ch-elm | R4 | ch-elm-results-camp-org | CH ELM Results Camp Org | active | 2025-06 | ch | sct | ||
ch.fhir.ig.ch-elm | R4 | ch-elm-results-chol-org | CH ELM Results Chol Org | active | 2025-06 | ch | sct | ||
ch.fhir.ig.ch-elm | R4 | ch-elm-results-cjd-org | CH ELM Results Cjd Org | active | 2025-06 | ch | sct | ||
ch.fhir.ig.ch-elm | R4 | ch-elm-results-complete-spec | CH ELM Results Complete Spec | active | 2025-06 | ch | sct | ||
ch.fhir.ig.ch-elm | R4 | ch-elm-results-component-antibiotic-cpe | CH ELM Results Component Antibiotic for CPE | active | 2025-06 | ch | |||
ch.fhir.ig.ch-elm | R4 | ch-elm-results-component-gene-cpe | CH ELM Results Component Gene CPE | active | 2025-06 | ch | |||
ch.fhir.ig.ch-elm | R4 | ch-elm-results-diph-org | CH ELM Results Diph Org | active | 2025-06 | ch | sct | ||
ch.fhir.ig.ch-elm | R4 | ch-elm-results-diph-spec | CH ELM Results Diph Spec | active | 2025-06 | ch | |||
ch.fhir.ig.ch-elm | R4 | ch-elm-results-ebol-org | CH ELM Results Ebol Org | active | 2025-06 | ch | |||
ch.fhir.ig.ch-elm | R4 | ch-elm-results-ehec-org | CH ELM Results Ehec Org | active | 2025-06 | ch | |||
ch.fhir.ig.ch-elm | R4 | ch-elm-results-ehec-tox-org | CH ELM Results Ehec Tox Org | active | 2025-06 | ch | |||
ch.fhir.ig.ch-elm | R4 | ch-elm-results-component-gene-tb | CH ELM Results Gene Tb | active | 2025-06 | ch | loinc | ||
ch.fhir.ig.ch-elm | R4 | ch-elm-results-geni-spec | CH ELM Results Geni Spec | active | 2025-06 | ch | sct | ||
ch.fhir.ig.ch-elm | R4 | ch-elm-results-haem-org | CH ELM Results Haem Org | active | 2025-06 | ch | sct | ||
ch.fhir.ig.ch-elm | R4 | ch-elm-results-hanta-org | CH ELM Results Hanta Org | active | 2025-06 | ch | sct | ||
ch.fhir.ig.ch-elm | R4 | ch-elm-results-hiv-org | CH ELM Results Hiv Org | active | 2025-06 | ch | |||
ch.fhir.ig.ch-elm | R4 | ch-elm-results-inf-org | CH ELM Results Inf Org | active | 2025-06 | ch | |||
ch.fhir.ig.ch-elm | R4 | ch-elm-results-influenza-hxny-org | CH ELM Results Influenza Hxny Org | active | 2025-06 | ch | sct | ||
ch.fhir.ig.ch-elm | R4 | ch-elm-results-leg-org | CH ELM Results Leg Org | active | 2025-06 | ch | sct | ||
ch.fhir.ig.ch-elm | R4 | ch-elm-results-lis-org | CH ELM Results Lis Org | active | 2025-06 | ch | sct | ||
ch.fhir.ig.ch-elm | R4 | ch-elm-results-mal-org | CH ELM Results Mal Org | active | 2025-06 | ch | sct | ||
ch.fhir.ig.ch-elm | R4 | ch-elm-results-maldi-tof-org | CH ELM Results Maldi-tof Org | active | 2025-06 | ch | sct | ||
ch.fhir.ig.ch-elm | R4 | ch-elm-results-mea-org | CH ELM Results Mea Org | active | 2025-06 | ch | sct | ||
ch.fhir.ig.ch-elm | R4 | ch-elm-results-men-org | CH ELM Results Men Org | active | 2025-06 | ch | sct | ||
ch.fhir.ig.ch-elm | R4 | ch-elm-results-mpox-org | CH ELM Results Mpox Org | active | 2025-06 | ch | sct | ||
ch.fhir.ig.ch-elm | R4 | ch-elm-results-mpx-ctng | CH ELM Results Mpx Ctng | active | 2025-06 | ch | |||
ch.fhir.ig.ch-elm | R4 | ch-elm-results-mpx-sash | CH ELM Results Mpx Sash | active | 2025-06 | ch | |||
ch.fhir.ig.ch-elm | R4 | ch-elm-results-mpx-sashec | CH ELM Results Mpx Sashec | active | 2025-06 | ch | |||
ch.fhir.ig.ch-elm | R4 | ch-elm-results-pneu-org | CH ELM Results Pneu Org | active | 2025-06 | ch | sct | ||
ch.fhir.ig.ch-elm | R4 | ch-elm-results-sal-org-complete | CH ELM Results Sal Org Complete | active | 2025-06 | ch | sct | ||
ch.fhir.ig.ch-elm | R4 | ch-elm-results-sal-org | CH ELM Results Sal Org | active | 2025-06 | ch | sct | ||
ch.fhir.ig.ch-elm | R4 | ch-elm-results-shi-org | CH ELM Results Shi Org | active | 2025-06 | ch | sct | ||
ch.fhir.ig.ch-elm | R4 | ch-elm-results-sterile-spec | CH ELM Results Sterile Spec | active | 2025-06 | ch | sct | ||
ch.fhir.ig.ch-elm | R4 | ch-elm-results-tub-gen-org | CH ELM Results Tub Gen Org | active | 2025-06 | ch | |||
ch.fhir.ig.ch-elm | R4 | ch-elm-results-tub-org | CH ELM Results Tub Org | active | 2025-06 | ch | sct | ||
ch.fhir.ig.ch-elm | R4 | ch-elm-results-tub-spec | CH ELM Results Tub Spec | active | 2025-06 | ch | |||
ch.fhir.ig.ch-elm | R4 | ch-elm-results-tul-org | CH ELM Results Tul Org | active | 2025-06 | ch | sct | ||
ch.fhir.ig.ch-elm | R4 | ch-elm-results-virus-cult-org | CH ELM Results Virus Cult Org | active | 2025-06 | ch | sct | ||
ch.fhir.ig.ch-elm | R4 | ch-elm-results-component-antibiotic-tb | CH ELM Results Antibiotic Tb | active | 2025-06 | ch | loinc | ||
hl7.terminology | R5 | v3-RoleClassSame | RoleClassSame | active | 2014-03 | uv | tho | ||
hl7.terminology | R5 | v3-RoleStatusNormal | RoleStatusNormal | active | 2014-03 | uv | tho | ||
hl7.terminology | R5 | v3-ManagedParticipationStatusNormal | ManagedParticipationStatusNormal | active | 2014-03 | uv | tho | ||
hl7.terminology | R5 | v3-EntityStatusNormal | EntityStatusNormal | active | 2014-03 | uv | tho | ||
signal.core.r4 | R4 | questionnaire-ccars-mental-health-services-program | Questionnaire CCARS Mental Health Services Program | draft | 1 | pa | us | ||
hl7.fhir.us.pq-cmc-fda | R5 | pqcmc-genc-and-iso-intersect | GENC and ISO 3166 Intersection | trial-use | 2 | brr | 2025-07 | us | fhir |
hl7.fhir.au.base | R4 | amt-mp-codes | AMT Medicinal Product and Substances | trial-use | 3 | 2025-06 | au | sct | |
hl7.fhir.au.base | R4 | rsg-source-document-type | AU Recorded Sex or Gender (RSG) Source Document Type | trial-use | 1 | 2025-06 | au | tho loinc | |
hl7.fhir.au.base | R4 | rsg-type | AU Recorded Sex or Gender Type | trial-use | 1 | 2025-06 | au | sct tho loinc | |
csiro.fhir.au.smartforms | R4 | AboriginalTorresStraitIslander | Aboriginal and/or Torres Strait Islander | draft | 2025-07 | au | |||
hl7.terminology | R5 | v3-ActStatusActive | ActStatusActive | active | 2014-03 | uv | tho | ||
hl7.terminology | R5 | v3-ActStatusCancelled | ActStatusCancelled | active | 2014-03 | uv | tho | ||
hl7.terminology | R5 | v3-ActStatusAborted | ActStatusAborted | active | 2014-03 | uv | tho | ||
hl7.fhir.us.carin-bb | R4 | ADAUniversalNumberingSystem | American Dental Association Universal Numbering Value Set | trial-use | fm | 2025-02 | us | tho | |
fhir.argonaut.clinicalnotes | R3 | diagnosticreport-category | Argonaut DiagnosticReport Category Value Set | draft | 2018-05 | us | loinc | ||
fhir.argonaut.clinicalnotes | R3 | documentreference-category | Argonaut DocumentReferences Category Value Set | draft | 2018-05 | us | internal | ||
fhir.argonaut.clinicalnotes | R3 | argonaut-clinical-note-type | Argonaut DocumentReferences Type Value Set | draft | 2018-05 | us | loinc | ||
fhir.argonaut.scheduling | R3 | visit-type | Argonaut Visit Types | active | 2017-07 | us | |||
csiro.fhir.au.smartforms | R4 | amt-vaccine-1 | Australian Medicines Terminology Vaccine | active | 2020-05 | au | sct | ||
csiro.fhir.au.smartforms | R4 | australian-pronouns-1 | Australian Pronouns | active | 2024-02 | au | tho loinc | ||
csiro.fhir.au.smartforms | R4 | australian-states-territories-2 | Australian States and Territories | active | 2020-05 | au | |||
csiro.fhir.au.smartforms | R4 | biological-sex-1 | Biological Sex | active | 2020-12 | au | sct | ||
OntarioacCDRFHIRImplementationGuide-0.10.00 | R4 | acCDR-encounter-priority | EncounterPriority | draft | ca | ||||
csiro.fhir.au.smartforms | R4 | CervicalScreeningStatus-1 | Cervical Screening Status | draft | 2025-07 | au | sct | ||
csiro.fhir.au.smartforms | R4 | clinical-condition-1 | Clinical Condition | active | 2020-05 | au | sct | ||
hl7.terminology | R5 | v3-ActClassConsent | ActClassConsent | active | 2014-03 | uv | tho | ||
ch.fhir.ig.ch-crl | R4 | nkrs-dssplus | NKRS - DSSplus | active | 2022-02 | ch | internal | ||
hl7.fhir.us.davinci-atr | R4 | atr-changetype | DaVinci ATR Change Types | trial-use | 2 | fm | 2020-09 | us | fhir |
hl7.fhir.us.davinci-atr | R4 | atr-attribution-list-status | DaVinci Attribution List Status | trial-use | 2 | fm | 2020-09 | us | fhir |